Skip to main content
. Author manuscript; available in PMC: 2020 Jul 7.
Published in final edited form as: Anticancer Res. 2019 May;39(5):2277–2287. doi: 10.21873/anticanres.13344

Figure 5.

Figure 5.

Distinct gene-expression profiling associated with the intraductal implantation of 4T1-Luc2-RFP cells. A: A heatmap displaying 6,375 genes that were differentially expressed after mammary intraductal (MIND) injection of 4T1-Luc2-RFP cells compared to non-injected 4T1-Luc2-RFP cells. B: Identification of differentially expressed genes in 4T1-Luc2-RFP post MIND injection compared to data of Tabaries et al. (30) of differentially expressed genes in 4T1 cells post mammary fat pad (MFD) injection (Venn diagram). C: Pathway analysis showing the number of differentially expressed genes in 4T1-Luc2-RFP post MIND injection.